Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- PMID: 39210207
- PMCID: PMC11914368
- DOI: 10.1007/s12094-024-03636-9
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
Abstract
Breast cancer, a prevalent malignancy among women, has various physical and psychological impacts. This comprehensive review offers an in-depth look at multidisciplinary dermo-aesthetic intervention approaches, emphasizing the balance between oncological therapies and the management of these effects. The information presented spans specialties such as aesthetic medicine, plastic surgery, dermatology, physiotherapy, nutrition, odontology, and gynecology. This review, which serves as a clinical guide, aims to establish a safe protocol for non-medical interventions involving oncologists, physicians, and specialists from various areas in patients with breast cancer focused on improving their quality of life. This work offers personalized and integrative care strategies for the eradication of cancer. However, it is still necessary for patients to consult with their oncologist before undergoing any dermo aesthetic treatment. However, it is still necessary for patients to consult with their oncologist before undergoing any dermo aesthetic treatment.
Keywords: Aesthetic medicine; BC; Integrative care; Multidisciplinary treatment; Oncology rehabilitation; Quality of life.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: Alejandro Falcón González has served an advisory role for Pfizer, Astra-Zeneca, Novartis, Steve, and Gilead. Additionally, he has been part of the speaker bureau for Pfizer, Novartis, Lilly, Astra-Zeneca, Daichii, Eisai, Grünenthal, Seagen, and Gilead. Maria Rivero and Rocio Ramos are employees of and may own stock in Pfizer Inc. Elena Galve Calvo, María Isabel Gallegos Sancho, and Ricardo López Martos received honoraria from Pfizer for their collaboration in the preparation of this manuscript. The remaining authors declare no conflicts of interest. Ethical approval: This article does not contain any studies with human participants performed by any of the authors. Consent to participate and publication: The manuscript has been read and approved for submission by all the named authors.
Figures
References
-
- Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull. 2010;57:B4184. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
